查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1455225

2024 年干粉吸入器全球市场报告

Dry Powder Inhaler Global Market Report 2024
出版日期: 按订单生产 | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10个工作天内

价格
简介目录

干粉吸入器市场规模预计未来几年将稳定成长。预计到 2028 年将以 5.0% 的复合年增长率 (CAGR) 增长至 258.2 亿美元。预测期内的预期成长是由对永续性的持续重视、全球都市化趋势、製造流程的进步、支持永续建设的政府激励措施和政策以及全球经济因素所推动的。这被认为是由于这个原因。预测期内预计的主要趋势包括建设产业研究和开发的增加、对传统建筑技术的新兴趣、材料技术的进步、不断发展的建筑和设计趋势以及永续建筑实践。例子包括监管支援。

呼吸系统疾病盛行率的预期增加将推动未来干粉吸入器市场的成长。呼吸系统疾病包括影响呼吸系统的多种疾病，干粉吸入器在气喘、慢性阻塞性肺病和囊肿纤维化等疾病的治疗中发挥重要作用。这些吸入器将药物直接输送到肺部，使其成为治疗呼吸系统疾病的传统药物输送方法的有前途的替代方案。例如，澳洲健康与福利研究所2023年6月的报告显示，澳洲呼吸系统疾病相关死亡人数从2020年的43,031人增加到2021年的46,551人。因此，呼吸系统疾病的日益普及预计将推动干粉吸入器市场的成长。

空气污染水平的增加预计也将促进干粉吸入器市场的成长。空气污染（以空气中各种污染物的浓度来衡量）会导致呼吸问题，因此干粉吸入器有助于减轻症状并控制因空气中污染物而加剧的呼吸道症状。已成为以下药物的首选给药物方法： 2022年，美国环保署报告称，约6,600万吨污染物被释放到美国大气中。此外，2023年3月，IQAir报告称，伊拉克是污染第二严重的国家，其PM2.5浓度为80.1μg/m3，是世界卫生组织2022年PM2.5年度指引值的16倍。空气污染的加剧预计将推动干粉吸入器市场的成长。

目录

第一章执行摘要

第二章 市场特点

第三章 市场趋势与策略

第四章宏观经济情景

  • 高通膨对市场的影响
  • 乌克兰与俄罗斯战争对市场的影响
  • COVID-19 对市场的影响

第五章世界市场规模与成长

  • 全球干粉吸入器市场驱动与阻碍因素
    • 市场驱动力
    • 市场限制
  • 2018-2023年全球干粉吸入器市场规模、表现与成长
  • 2023-2028、2033年全球干粉吸入器市场规模及成长预测

第六章市场区隔

  • 全球干粉吸入器市场，依产品、性能及预测细分，2018-2023、2023-2028、2033
  • 单剂量吸入器
  • 多剂量吸入器
  • 全球干粉吸入器市场，依功能细分、实际及预测，2018-2023、2023-2028、2033
  • 手动吸入器
  • 数位操作吸入器
  • 全球干粉吸入器市场，按应用、性能和预测细分，2018-2023、2023-2028、2033
  • 气喘
  • 慢性阻塞性肺病（COPD）
  • 囊肿纤维化
  • 其他用途
  • 全球干粉吸入器市场，依最终用户细分，实际和预测，2018-2023、2023-2028、2033
  • 医院和诊所
  • 家庭护理设置
  • 门诊手术中心
  • 其他最终用户

第 7 章 区域与国家分析

  • 全球干粉吸入器市场，按地区、业绩和预测，2018-2023、2023-2028、2033
  • 全球干粉吸入器市场，依国家、绩效及预测，2018-2023、2023-2028、2033

第八章亚太市场

第九章 中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第14章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章 义大利市场

第20章 西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章加拿大市场

第26章 南美洲市场

第27章 巴西市场

第28章 中东市场

第29章 非洲市场

第三十章 竞争格局及公司概况

  • 干粉吸入器市场竞争格局
  • 干粉吸入器市场公司概况
    • Novartis AG
    • AstraZeneca plc.
    • GlaxoSmithKline Plc
    • 3M Company
    • Boehringer Ingelheim GmbH

第三十一章 其他重大及创新企业

  • Viatris（Mylan NV）
  • Otsuka Pharmaceutical Co. Ltd
  • Sun Pharmaceutical Industries Limited
  • Catalent Inc.
  • Aptar Group Inc.
  • Chiesi Farmaceutici SpA
  • Recipharm AB
  • Cipla Limited
  • Lupin Limited
  • Orion Corporation
  • OPKO Health
  • Zhejiang Hisun Pharmaceutical Co Ltd
  • Beximco Pharmaceuticals Ltd
  • Sava Healthcare Ltd.
  • Hovione

第32章竞争基准化分析

第 33 章. 竞争对手仪表板

第三十四章 重大併购

第35章 未来前景与可能性分析

第36章附录

简介目录
Product Code: r16226

A dry powder inhaler (DPI) is a medical device designed for delivering medication in the form of dry powder directly to the lungs. It is primarily used for treating respiratory disorders such as asthma and chronic obstructive pulmonary disease (COPD). To effectively use a DPI, it is crucial for the user to inhale rapidly and deeply, allowing the medication to reach the lungs.

The main types of dry powder inhalers include single-dose inhalers and multi-dose inhalers. Single-dose inhalers are devices that administer medication directly to the lungs in the form of dry powder. These devices can be either manually operated or digitally operated, and they find applications in treating conditions such as asthma, COPD, cystic fibrosis, and others. Various end-users, including hospitals and clinics, homecare settings, and ambulatory surgical centers, utilize these inhalers.

The dry powder inhaler market research report is one of a series of new reports from The Business Research Company that provides dry powder inhaler market statistics, including dry powder inhaler industry global market size, regional shares, competitors with a dry powder inhaler market share, detailed dry powder inhaler market segments, market trends and opportunities, and any further data you may need to thrive in the dry powder inhaler industry. This dry powder inhaler market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The dry powder inhaler market size has grown strongly in recent years. It will grow from $20.18 billion in 2023 to $21.25 billion in 2024 at a compound annual growth rate (CAGR) of 5.3%. The growth observed in the historical period can be attributed to factors such as renewed interest in sustainable building materials, cultural preservation and heritage restoration, the rise in green building practices, local sourcing, community involvement, and regulatory support including building codes.

The dry powder inhaler market size is expected to see steady growth in the next few years. It will grow to $25.82 billion in 2028 at a compound annual growth rate (CAGR) of 5.0%. The anticipated growth in the forecast period can be attributed to continued emphasis on sustainability, global urbanization trends, advancements in manufacturing processes, government incentives and policies supporting sustainable construction, and global economic factors. Major trends expected in the forecast period include increased research and development in the construction industry, renewed interest in traditional building techniques, advancements in material technology, evolving architectural and design trends, and regulatory support for sustainable construction practices.

The anticipated increase in the prevalence of respiratory diseases is poised to drive the growth of the dry powder inhaler market in the future. Respiratory diseases encompass a wide range of medical conditions affecting the respiratory system, and dry powder inhalers play a crucial role in treating conditions such as asthma, COPD, and cystic fibrosis. These inhalers deliver medication directly to the lungs, offering a promising alternative to traditional drug delivery methods for respiratory diseases. For example, reports from the Australian Institute of Health and Welfare in June 2023 indicated a rise in respiratory disease-related deaths from 43,031 in 2020 to 46,551 in 2021 in Australia. Thus, the growing prevalence of respiratory diseases is expected to propel the growth of the dry powder inhaler market.

The increasing levels of air pollution are also anticipated to contribute to the growth of the dry powder inhaler market. Air pollution, measured by the concentration of various pollutants in the atmosphere, leads to respiratory issues, making dry powder inhalers a preferred delivery method for medications that alleviate symptoms and manage respiratory conditions exacerbated by airborne pollutants. In 2022, the United States Environmental Protection Agency reported approximately 66 million tons of pollutants released into the atmosphere in the United States. Additionally, in March 2023, IQAir reported that Iraq was the second most polluted country with 80.1 µg/m3, 16 times higher than the WHO PM2.5 annual guideline in 2022. Therefore, the rising levels of air pollution are expected to drive the growth of the dry powder inhaler market.

The stringent regulatory guidelines are anticipated to pose challenges to the growth of the dry powder inhaler market. The imposition of rigorous testing and compliance requirements has increased the hurdles for product development, usage, and market entry. In September 2023, The Scottish Government released a consultation draft guidance on quality prescribing for respiratory illness, emphasizing the importance of effective use of dry powder inhalers (DPIs) and providing information on inhaler choice and technique. Strict regulatory guidelines may impede the growth of the dry powder inhaler market.

Major companies in the dry powder inhaler market are focusing on innovation, developing products with muscarinic antagonists for the treatment of chronic obstructive pulmonary disease (COPD), and expanding their product portfolios. Muscarinic antagonists are drugs that inhibit the muscarinic acetylcholine receptor and are used to treat various illnesses, including COPD. For instance, Glenmark Pharmaceuticals Limited launched Tiogiva, a long-acting muscarinic antagonist dry powder inhaler (DPI) for COPD treatment in the UK in June 2021. The DPI functions by relaxing the muscles in the airways, facilitating breathing and requiring only once-a-day usage.

In February 2021, Catalent Inc. acquired Acorda Therapeutics Inc., expanding its capabilities in DPI manufacturing and adding a commercial-stage product to its portfolio, emphasizing the growing significance of DPI therapies for respiratory and neurological diseases. Acorda Therapeutics Inc. produces various DPIs for patients with respiratory diseases.

Major companies operating in the dry powder inhaler market report are Novartis AG, AstraZeneca plc., GlaxoSmithKline PLC, 3M Company, Boehringer Ingelheim GmbH, Viatris (Mylan N.V), Otsuka Pharmaceutical Co. Ltd., Sun Pharmaceutical Industries Limited, Catalent Inc., Aptar Group Inc., Chiesi Farmaceutici S.p.A., Recipharm AB, Cipla Limited, Lupin Limited, Orion Corporation, OPKO Health, Zhejiang Hisun Pharmaceutical Co Ltd., Beximco Pharmaceuticals Ltd., Sava Healthcare Ltd., Hovione, Elpen S.A., MannKind Corporation, Meda Pharmaceuticals, Presspart Manufacturing Ltd., SMB Laboratories SA, Teva Pharmaceutical Industries Limited, Pharmaxis Ltd., Iconovo AB, SRS Pharmaceuticals Pvt. Ltd.

North America was the largest region in the dry powder inhaler market in 2023. The regions covered in the dry powder inhaler market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the Dry Powder Inhaler market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The dry powder inhaler market consists of sales of dry powder forms, spiriva handihalers, breath-activated inhalers, rotahalers, diskus devices, and twisthaler inhalers. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Dry Powder Inhaler Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on dry powder inhaler market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for dry powder inhaler ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The dry powder inhaler market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Product: Single-Dose Inhalers; Multi-Dose Inhalers
  • 2) By Function: Manually Operated Inhaler Devices; Digitally Operated Inhaler Devices
  • 3) By Application: Asthma; Chronic Obstructive Pulmonary Disease (COPD); Cystic Fibrosis; Other Applications
  • 4) By End User: Hospitals And Clinics; Homecare Settings; Ambulatory Surgical Centers; Other End Users
  • Companies Mentioned: Novartis AG; AstraZeneca plc.; GlaxoSmithKline Plc; 3M Company; Boehringer Ingelheim GmbH
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Dry Powder Inhaler Market Characteristics

3. Dry Powder Inhaler Market Trends And Strategies

4. Dry Powder Inhaler Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Dry Powder Inhaler Market Size and Growth

  • 5.1. Global Dry Powder Inhaler Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Dry Powder Inhaler Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Dry Powder Inhaler Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Dry Powder Inhaler Market Segmentation

  • 6.1. Global Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Single-Dose Inhalers
  • Multi-Dose Inhalers
  • 6.2. Global Dry Powder Inhaler Market, Segmentation By Function, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Manually Operated Inhaler Devices
  • Digitally Operated Inhaler Devices
  • 6.3. Global Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Asthma
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Cystic Fibrosis
  • Other Applications
  • 6.4. Global Dry Powder Inhaler Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals And Clinics
  • Homecare Settings
  • Ambulatory Surgical Centers
  • Other End Users

7. Dry Powder Inhaler Market Regional And Country Analysis

  • 7.1. Global Dry Powder Inhaler Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Dry Powder Inhaler Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Dry Powder Inhaler Market

  • 8.1. Asia-Pacific Dry Powder Inhaler Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Dry Powder Inhaler Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Dry Powder Inhaler Market

  • 9.1. China Dry Powder Inhaler Market Overview
  • 9.2. China Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Dry Powder Inhaler Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Dry Powder Inhaler Market

  • 10.1. India Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Dry Powder Inhaler Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Dry Powder Inhaler Market

  • 11.1. Japan Dry Powder Inhaler Market Overview
  • 11.2. Japan Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Dry Powder Inhaler Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Dry Powder Inhaler Market

  • 12.1. Australia Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Dry Powder Inhaler Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Dry Powder Inhaler Market

  • 13.1. Indonesia Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Dry Powder Inhaler Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Dry Powder Inhaler Market

  • 14.1. South Korea Dry Powder Inhaler Market Overview
  • 14.2. South Korea Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Dry Powder Inhaler Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Dry Powder Inhaler Market

  • 15.1. Western Europe Dry Powder Inhaler Market Overview
  • 15.2. Western Europe Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Dry Powder Inhaler Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Dry Powder Inhaler Market

  • 16.1. UK Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Dry Powder Inhaler Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Dry Powder Inhaler Market

  • 17.1. Germany Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Dry Powder Inhaler Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Dry Powder Inhaler Market

  • 18.1. France Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Dry Powder Inhaler Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Dry Powder Inhaler Market

  • 19.1. Italy Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Dry Powder Inhaler Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Dry Powder Inhaler Market

  • 20.1. Spain Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Dry Powder Inhaler Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Dry Powder Inhaler Market

  • 21.1. Eastern Europe Dry Powder Inhaler Market Overview
  • 21.2. Eastern Europe Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Dry Powder Inhaler Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Dry Powder Inhaler Market

  • 22.1. Russia Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Dry Powder Inhaler Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Dry Powder Inhaler Market

  • 23.1. North America Dry Powder Inhaler Market Overview
  • 23.2. North America Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Dry Powder Inhaler Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Dry Powder Inhaler Market

  • 24.1. USA Dry Powder Inhaler Market Overview
  • 24.2. USA Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Dry Powder Inhaler Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Dry Powder Inhaler Market

  • 25.1. Canada Dry Powder Inhaler Market Overview
  • 25.2. Canada Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Dry Powder Inhaler Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Dry Powder Inhaler Market

  • 26.1. South America Dry Powder Inhaler Market Overview
  • 26.2. South America Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Dry Powder Inhaler Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Dry Powder Inhaler Market

  • 27.1. Brazil Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Dry Powder Inhaler Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Dry Powder Inhaler Market

  • 28.1. Middle East Dry Powder Inhaler Market Overview
  • 28.2. Middle East Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Dry Powder Inhaler Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Dry Powder Inhaler Market

  • 29.1. Africa Dry Powder Inhaler Market Overview
  • 29.2. Africa Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Dry Powder Inhaler Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Dry Powder Inhaler Market Competitive Landscape And Company Profiles

  • 30.1. Dry Powder Inhaler Market Competitive Landscape
  • 30.2. Dry Powder Inhaler Market Company Profiles
    • 30.2.1. Novartis AG
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. AstraZeneca plc.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. GlaxoSmithKline Plc
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. 3M Company
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Boehringer Ingelheim GmbH
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Dry Powder Inhaler Market Other Major And Innovative Companies

  • 31.1. Viatris (Mylan N.V)
  • 31.2. Otsuka Pharmaceutical Co. Ltd
  • 31.3. Sun Pharmaceutical Industries Limited
  • 31.4. Catalent Inc.
  • 31.5. Aptar Group Inc.
  • 31.6. Chiesi Farmaceutici S.p.A.
  • 31.7. Recipharm AB
  • 31.8. Cipla Limited
  • 31.9. Lupin Limited
  • 31.10. Orion Corporation
  • 31.11. OPKO Health
  • 31.12. Zhejiang Hisun Pharmaceutical Co Ltd
  • 31.13. Beximco Pharmaceuticals Ltd
  • 31.14. Sava Healthcare Ltd.
  • 31.15. Hovione

32. Global Dry Powder Inhaler Market Competitive Benchmarking

33. Global Dry Powder Inhaler Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Dry Powder Inhaler Market

35. Dry Powder Inhaler Market Future Outlook and Potential Analysis

  • 35.1 Dry Powder Inhaler Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Dry Powder Inhaler Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Dry Powder Inhaler Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer